Shares of Novo Nordisk dropped over 24% after disappointing results in a trial for its CagriSema weight loss drug, which fell short of expectations with a 22.7% weight reduction. The stock recovered slightly to trade down 18.8%, while rival Eli Lilly’s obesity drug saw a 5% rise. Novo plans to further explore CagriSema’s potential after outperforming Wegovy in weight loss, with regulatory submission expected by 2025.
Full Article
Plane suddenly drops 500 feet to ‘avoid mid-air collision’ with British jet fighter
A Southwest Airlines flight experienced a sudden drop of 500 feet shortly after takeoff from Hollywood Burbank Airport to avoid a mid-air collision with a Hawker Hunter jet. Passengers reported panic during the incident, though the plane landed safely in Las Vegas, with no major injuries except for two flight attendants receiving medical attention. Want More Context? 🔎
Read more